Trial Profile
Study of the Effect of PROGRESSive Withdrawal Esomeprazole of on Acid-related Symptoms, PROGRESS Study A Randomized, Placebo-controlled, Double Blinded Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 May 2023
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary)
- Indications Gastric disorders
- Focus Therapeutic Use
- Acronyms PROGRESS
- 24 May 2023 Planned number of patients changed from 156 to 58.
- 24 May 2023 Status changed from recruiting to active, no longer recruiting.
- 03 Jan 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2023.